Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome

Journal of Clinical Investigation

Volumn 101, Issue 6, 1998, Pages 1310-1317

  Lomri, A ^a   Lemonnier, J ^a   Hott, M ^a   De Parseval, N ^b   Lajeunie, E ^b   Munnich, A ^b   Renier, D ^b   Marie, P J ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Apert syndrome; Calvaria; Craniosynostosis; Fibroblast growth factor receptor 2 mutations; Osteogenesis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR;

ACROCEPHALOSYNDACTYLY; ARTICLE; BONE MATRIX; CALVARIA; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL;

ACROCEPHALOSYNDACTYLIA; ALKALINE PHOSPHATASE; AMINO ACID SUBSTITUTION; BLOTTING, NORTHERN; BONE MATRIX; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COLLAGEN; FETUS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HISTOCYTOCHEMISTRY; HUMANS; INFANT; NITROPHENOLS; OSTEOGENESIS; POINT MUTATION; RECEPTORS, FIBROBLAST GROWTH FACTOR; SERINE; SKULL; TRYPTOPHAN;

EID: 0032521181     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Apert, M.E. 1906. De l'acrocéphalosyndactilie. Bull. Soc. Med. Hôp. Paris. 23:1310-1313.
2. Wilkie, A.O.M., S.F. Slaney, M. Oldridge, M.D. Poole, G.J. Asworth, A.D. Hockley, R.D. Hayward, D.J. David, L.J. Pulleyn, P. Rutland, et al. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9:165-172.
3. Jabs, E.W., X. Li, A.F. Scott, G. Meyers, W. Chen, M. Eccles, J.-I. Mao, L.R. Charnas, C.E. Jackson, and M. Jaye. 1994. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat. Genet. 8:275-279.
4. Reardon, W., R.M. Winter, P. Rutland, L.J. Pulleyn, B.M. Jones, and S. Malcolm. 1994. Mutations in the fibroblast growth factor-2 gene cause Crouzon syndrome. Nat. Genet. 4:98-103.
5. Muenke, M., U. Schell, A. Hehr, N.H. Robin, W. Losken, A. Schinzel, L.J. Pulleyn, P. Rutland, W. Reardon, S. Malcom, and R.M. Winter. 1994. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8:269-274.
6. Lajeunie, E., H.W. Ma, J. Bonaventure, A. Munnich, and M. Le Merrer. 1995. FGFR-2 mutations in Pfeiffer syndrome. Nat. Genet. 9:108-110.
7. Rutland, P., L. Pulleyn, W. Reardon, M. Baraitser, R. Hayward, B. Jones, S. Malcolm, R.M. Winter, M. Oldridge, S.F. Slaney, et al. 1995. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat. Genet. 9:173-176.
8. Johnson, D., and L. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
9. Wilkie, A.O.M., G.M. Morriss-Kay, E.Y. Jones, and J.K. Heath. 1995. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5:1-9.
10. Naski, M.C., Q. Wang, J. Xu, and M. Ornitz. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13:233-237.
11. Neilson, K.M., and R.E. Friesel. 1995. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270:26037-26040.
12. Galvin, B.D., K.C. Hart, A.N. Meyer, M.K. Webster, and D.J. Donoghue. 1996. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc. Natl. Acad. Sci. USA. 93:7894-7899.
13. Park, W.J., C. Theda, N.E. Maestri, G.A. Meyers, J.S. Fryburg, C. Dufresne, and M.M. Cohen. 1995. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57:321-328.
14. Kimelman, D., and M. Kirschner. 1987. Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell. 51:869-877.
15. Globus, R.K., P. Patterson-Buckendahl, and D. Gospodarowicz. 1988. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology. 123:98-105.
16. Canalis, E., M. Centrella, and T. McCarthy. 1988. Effects of fibroblast growth factor on bone formation in vitro. J. Clin. Invest. 81:1572-1577.
17. McCarthy, T.L., M. Centrella, and E. Canalis. 1989. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal cells. Endocrinology. 125:2118-2126.
18. Rodan, S.B., G. Wesolowski, K.A. Thomas, K. Yoon, and G.A. Rodan. 1989. Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect. Tissue Res. 20:283-288.
19. Hurley, M.M., C. Abreu, J.R. Harrisson, A.C. Lichtler, L.G. Raisz, and B.E. Kream. 1993. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268:5588-5593.
20. Noff, D., S. Pitaru, and N. Savion. 1989. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS (Fed. Eur. Biochem. Soc.) Lett. 250:619-621.
21. Pitaru, S., S. Kotev-Emeth, D. Noff, S. Kaffuler, and N. Savion. 1993. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J. Bone Miner. Res. 8:919-929.
22. Hanada, K., E.J. Dennis, and A.I. Caplan. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. .J. Bone Miner. Res. 12:1606-1614.
23. Martin, I., A. Muraglia, G. Campanile, R. Cancedda, and R. Quarto. 1997. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 138:4456-4462.
24. Nakamura, T., K. Hanada, M. Tamura, T. Shibanushi, H. Nigi, M. Tagawa, S. Fukumoto, and T. Matsumoto. 1995. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology. 136:1276-1284.
25. Mayahara, H., T. Ito, H. Nagai, H. Miyajima, R. Tsukuda, S. Taketomi, J. Mizoguchi, and K. Kato. 1993. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors. 9:73-80.
26. De Pollak, C., E. Arnaud, D. Rénier, and P.J. Marie. 1997. Age-related changes in bone formation, osteoblastic cell proliferation and differentiation during postnatal osteogenesis in human calvaria. J. Cell. Biochem. 64:128-139.
27. De Pollak, C., D. Renier, M. Hott, and P.J. Marie. 1996. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J. Bone Miner. Res. 11:401-107.
28. Baron, R., A. Vignery, L. Neff, A. Silverglate, and A.S. Maria. 1983. Processings of undecalcified bone specimens for bone histomorphometry. In Bone Histomorphometry. R.R. Recker, editor. CRC Press, Inc., Boca Raton. FL. 13-36.
29. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J. Kanis, H. Malluche, P.J. Meunier, S. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols and units. J. Bone Miner. Res. 2:595-610.
30. Marie, P.J., M.C. de Vernejoul, D. Connes, and M. Hott. 1991. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J. Clin. Invest. 88:1167-1172.
31. Lomri, A., O. Fromigué, M. Hott, and P.J. Marie. 1995. Establishment of a new osteogenic cell line derived from normal human endosteal osteoblastic cells after functional insertion of the SV40 large T antigen. J. Bone Miner. Res. 10:S213. (Abstr.)
32. Chentoufi, J., M. Hott, D. Lamblin, M.H. Buc-Caron, P.J. Marie, and O. Kellermann. 1993. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation. 53:181-189.
33. Hott, M., and P.J. Marie. 1987. Glycol methacrylate as an embedding medium for bone tissue. Stain Technol. 62:51-57.
34. Jaye, M., J. Schlessinger, and C.A. Dionne. 1992. Fibroblast growth factor receptor kinases: molecular analysis and signal transduction. Biochem. Biophys. Acta. 1135:185-199.
35. Ornitz, D.M., and P. Leder. 1992. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267:16305-16311.
36. Newberry, E.P., J.M. Boudreaux, and D.A. Towler. 1996. The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motif. Mol. Endocrinol. 10:1029-1040.
37. Maher, P. 1996. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:529-536.
38. Stachowiak, M.K., P.A. Maher, A. Joy, E. Mordechai, and E.K. Stachowiak. 1996. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol. Biol. Cell. 7:1299-1317.
39. Turksen, K., and J.E. Aubin. 1991. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell Biol. 114:373-384.
40. Webster, M.K., P.Y. D'Avis, S.C. Robertson, and D.J. Donoghue. 1996. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16:4081-4087.
41. Webster, M.K., and D.J. Donoghue. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO (Eur. Mol. Biol. Organ.) J. 15:520-527.
42. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:911-921.